SAREPTA THERAPEUTICS, INC.

Profile

Company Names

SAREPTA THERAPEUTICS, INC.

Addresses

215 FIRST STREET, SUITE 415, CAMBRIDGE, MA 02142

Phone Numbers

617-274-4000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$430,499,960.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-02-14 
$399,999,980.00 
$399,999,980.00 
$0.00 
Equity 
1
2019-11-13 
$30,499,980.00 
$30,499,980.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
J. 
BARRY 
DIRECTOR
BLACK BEAR FUND II LLC   |  ELCELYX THERAPEUTICS, INC.   |  SAREPTA THERAPEUTICS, INC.
M. 
KATHLEEN 
BEHRENS 
DIRECTOR
SAREPTA THERAPEUTICS, INC.
MICHAEL 
W. 
BONNEY 
DIRECTOR
SAREPTA THERAPEUTICS, INC.
WILLIAM 
 
CIAMBRONE 
EXECUTIVE OFFICER
SAREPTA THERAPEUTICS, INC.
ALEXANDER 
 
CUMBO 
EXECUTIVE OFFICER
SAREPTA THERAPEUTICS, INC.
MARY ANN 
 
GRAY 
DIRECTOR
ACADIA PHARMACEUTICALS INC   |  SAREPTA THERAPEUTICS, INC.   |  SENECA BIOPHARMA, INC.   |  PALISADE BIO, INC.
DAVID 
TYRONNE 
HOWTON 
EXECUTIVE OFFICER
SAREPTA THERAPEUTICS, INC.   |  SOLID BIOSCIENCES INC.
DOUGLAS 
S. 
INGRAM 
EXECUTIVE OFFICER, DIRECTOR
NEMUS BIOSCIENCE, INC.   |  SAREPTA THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.
SANDESH 
 
MAHATME 
EXECUTIVE OFFICER
SAREPTA THERAPEUTICS, INC.   |  NATIONAL RESILIENCE, INC.
JOHN 
C. 
MARTIN 
DIRECTOR
SAREPTA THERAPEUTICS, INC.
CLAUDE 
 
NICAISE 
DIRECTOR
SAREPTA THERAPEUTICS, INC.   |  CHEMOMAB THERAPEUTICS LTD.
GILMORE 
 
O-NEILL 
EXECUTIVE OFFICER
SAREPTA THERAPEUTICS, INC.
HANS 
 
WIGZELL 
DIRECTOR
SAREPTA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-02-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-02-14 
2019-11-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#